Vigonvita Life Sciences Co (HKSE:02630) Altman Z2-Score: -2.49 (As of Jul. 28, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02630 Vigonvita Life Sciences Co Ltd HKSE:02630
8 GF Score
Price HK$90.00
! 2 Warning Signs
View Full Analysis

What is Vigonvita Life Sciences Co Altman Z2-Score?

Vigonvita Life Sciences Co HKSE:02630 +5.32% 8 Altman Z2-Score is -2.49 as of Jul. 28, 2026. GuruFocus rates HKSE:02630 with a GF Score™ of 8/100. The stock has 2 warning signs investors should review. Among 990 Drug Manufacturers companies, Vigonvita Life Sciences Co ranks worse than 83.03% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Warning Sign:

Vigonvita Life Sciences Co has a Altman Z2-Score of -2.49, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Vigonvita Life Sciences Co's Altman Z2-Score or its related term are showing as below:

HKSE:02630' s Altman Z2-Score Range Over the Past 10 Years
Min: -4.02   Med: -2.49   Max: -0.6
Current: -2.49

During the past 3 years, Vigonvita Life Sciences Co's highest Altman Z2-Score was -0.60. The lowest was -4.02. And the median was -2.49.


Vigonvita Life Sciences Co  (HKSE:02630) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Vigonvita Life Sciences Co Altman Z2-Score Related Terms


Vigonvita Life Sciences Co Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for Vigonvita Life Sciences Co's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vigonvita Life Sciences Co Altman Z2-Score Chart

Vigonvita Life Sciences Co Annual Data
Trend Dec23 Dec24 Dec25
Altman Z2-Score
-0.60 -4.02 -2.49

Vigonvita Life Sciences Co Semi-Annual Data
Dec23 Dec24 Dec25
Altman Z2-Score -0.60 -4.02 -2.49

HKSE:02630 vs LLY, JNJ, ABBV: Altman Z2-Score Comparison

For the Drug Manufacturers - General subindustry, Vigonvita Life Sciences Co's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vigonvita Life Sciences Co Altman Z2-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vigonvita Life Sciences Co's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Vigonvita Life Sciences Co's Altman Z2-Score falls into.


HKSE:02630
8GF Score
Vigonvita Life Sciences Co Ltd HKSE:02630
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vigonvita Life Sciences Co Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Vigonvita Life Sciences Co's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.0288+3.26*-0.4398+6.72*-0.2665+1.05*0.5227
=-2.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2025:
Total Assets was HK$1,424.3 Mil.
Total Current Assets was HK$620.1 Mil.
Total Current Liabilities was HK$579.1 Mil.
Retained Earnings was HK$-626.5 Mil.
Pre-Tax Income was HK$-394.3 Mil.
Interest Expense was HK$-14.8 Mil.
Total Liabilities was HK$943.0 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(620.08 - 579.125)/1424.348
=0.0288

X2=Retained Earnings/Total Assets
=-626.468/1424.348
=-0.4398

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-394.281 - -14.757)/1424.348
=-0.2665

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(492.953 - 0)/943.018
=0.5227

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Vigonvita Life Sciences Co has a Altman Z2-Score of -2.49 indicating it is in Distress Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of -2.49 mean?
Vigonvita Life Sciences Co (HKSE:02630) has a Altman Z2-Score of -2.49 as of Jul. 28, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Vigonvita Life Sciences Co and its competitors. According to the industry distribution chart, Vigonvita Life Sciences Co ranks #822 out of 990 companies in the Drug Manufacturers industry, placing it in the top 83%.
Is Vigonvita Life Sciences Co's Altman Z2-Score too high?
Vigonvita Life Sciences Co's current Altman Z2-Score is -2.49. Based on the distribution chart, Vigonvita Life Sciences Co ranks #822 out of 990 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Vigonvita Life Sciences Co has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Vigonvita Life Sciences Co's Altman Z2-Score compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Vigonvita Life Sciences Co ranks #822 out of 990 companies for Altman Z2-Score. This places Vigonvita Life Sciences Co in the lower half of its industry. The industry median Altman Z2-Score is 3.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Drug Manufacturers company?
The median Altman Z2-Score among Drug Manufacturers companies is 3.85, based on 990 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Vigonvita Life Sciences Co and its competitors. For the Drug Manufacturers industry, the median Altman Z2-Score is 3.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vigonvita Life Sciences Co's current Altman Z2-Score is -2.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vigonvita Life Sciences Co stock overvalued right now?
Vigonvita Life Sciences Co (HKSE:02630) has a current Altman Z2-Score of -2.49. The current Altman Z2-Score is -2.49. Vigonvita Life Sciences Co's overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For Vigonvita Life Sciences Co (HKSE:02630), the current Altman Z2-Score is -2.49 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vigonvita Life Sciences Co Business Description

Address No. 108, Yuxin Road, 8th Floor, Building A, Suzhou Industrial Park District, Suzhou, CHN, 215123
Vigonvita Life Sciences Co Ltd biopharmaceutical company. It is focused on innovation driven biopharmaceutical development, with a strategic emphasis on addressing unmet clinical needs in the treatment of neuropsychiatric, infectious, and andrological diseases. The company's core Products include LV232, anti-depression drug candidate, VV913: a novel investigational drug candidate for premature ejaculation and, VV116: an oral nucleoside analog with broad-spectrum antiviral potential. The company's operations are located in the PRC and Uzbekistan. Revenue is generated from the out-licensing and the sales of its pharmaceutical products.
8GF Score

Get the complete analysis for HKSE:02630

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$90.00
Price